David Grainger
Impact in
- Psychiatry and Mental health top 10%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Economics and Econometrics top 10%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 11
- Pharmaceutical Economics and Policy 4
- Economic and Financial Impacts of Cancer 2
-
- Schizophrenia research and treatment 4
- Co-authors
- K Downs (1 shared paper)Paul Trueman (1 shared paper)Josephine Mauskopf (4 shared papers)P. Joseph Gibson (2 shared papers)Josie Messina (2 shared papers)Scott W. Andersen (2 shared papers)Oye Gureje (1 shared paper)Timothy Lambert (1 shared paper)
- Journals
- International Journal of Technology Assessment in Health Care (3 papers)Patient (2 papers)Value in Health (2 papers)Schizophrenia Research (2 papers)PharmacoEconomics (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
David Grainger
19 papers receiving 288 citations
Peers
Comparison fields: 5 of 56
- Psychiatry and Mental health 120
- Economics and Econometrics 130
- Philosophy 19
- General Health Professions 34
- Pharmacology 9
Countries citing papers authored by David Grainger
This map shows the geographic impact of David Grainger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Grainger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Grainger more than expected).
Fields of papers citing papers by David Grainger
This network shows the impact of papers produced by David Grainger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Grainger. The network helps show where David Grainger may publish in the future.
Co-authors
The 25 scholars most cited alongside David Grainger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 71 | |
| 2 | 2010 | 67 | |
| 3 | 2012 | 37 | |
| 4 | Annual health outcomes and treatment costs for schizophrenia populations. | 1999 | 29 |
| 5 | 2002 | 21 | |
| 6 | 2012 | 16 | |
| 7 | 2016 | 15 | |
| 8 | 2016 | 10 | |
| 9 | 2010 | 10 | |
| 10 | 1998 | 10 | |
| 11 | 1998 | 7 | |
| 12 | 2022 | 4 | |
| 13 | 2017 | 3 | |
| 14 | 2012 | 2 | |
| 15 | 2011 | 1 | |
| 16 | 2013 | 1 | |
| 17 | 2017 | 1 | |
| 18 | 2015 | 1 | |
| 19 | 2017 | 1 |
About David Grainger
David Grainger is a scholar working on Economics and Econometrics, Psychiatry and Mental health, General Health Professions, Pharmacology and Physiology, having authored 19 papers that have together received 307 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (11 papers), Schizophrenia research and treatment (4 papers), Pharmaceutical Economics and Policy (4 papers), Mental Health and Patient Involvement (3 papers), Mental Health and Psychiatry (2 papers), Biomedical Ethics and Regulation (2 papers), Treatment of Major Depression (2 papers) and Economic and Financial Impacts of Cancer (2 papers). The work is most often cited by research in Psychiatry and Mental health (120 citations), Economics and Econometrics (130 citations), Philosophy (19 citations), General Health Professions (34 citations) and Pharmacology (9 citations). David Grainger has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include K Downs, Paul Trueman, Josephine Mauskopf, P. Joseph Gibson, Josie Messina, Scott W. Andersen, Oye Gureje, Timothy Lambert, Stanley V. Catts and John J. McGrath. Their work appears in journals such as International Journal of Technology Assessment in Health Care, Patient, Value in Health, Schizophrenia Research and PharmacoEconomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.